Schwarz, Par Go Head To Head Over Anxiety Drug
The patents for popular anti-anxiety drug Niravam have sparked a court battle between patent holder Schwarz Pharma and generics maker Par Pharmaceuticals....To view the full article, register now.
Already a subscriber? Click here to view full article